GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Debt-to-Asset

HeXun Biosciences Co (ROCO:6986) Debt-to-Asset : 0.05 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Debt-to-Asset?

HeXun Biosciences Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$3.0 Mil. HeXun Biosciences Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$32.0 Mil. HeXun Biosciences Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was NT$706.9 Mil. HeXun Biosciences Co's debt to asset for the quarter that ended in Dec. 2024 was 0.05.

HeXun Biosciences Co Debt-to-Asset Historical Data

The historical data trend for HeXun Biosciences Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Debt-to-Asset Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
0.30 0.25 0.17 0.12 0.05

HeXun Biosciences Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial 0.17 0.14 0.12 0.06 0.05

Competitive Comparison of HeXun Biosciences Co's Debt-to-Asset

For the Biotechnology subindustry, HeXun Biosciences Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeXun Biosciences Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's Debt-to-Asset falls into.


;
;

HeXun Biosciences Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

HeXun Biosciences Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.038 + 31.984) / 706.919
=0.05

HeXun Biosciences Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(3.038 + 31.984) / 706.919
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co  (ROCO:6986) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

HeXun Biosciences Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

HeXun Biosciences Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Debt-to-Asset
Comparable Companies
TPE:6838 ROCO:8279 ROCO:6733 ROCO:6864 TPE:1733 ROCO:6634 ROCO:6926 TPE:6794 ROCO:6945 ROCO:4911 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
Website
https://www.hexunbio.com
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines